共 56 条
[1]
Blach S(2017)Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study Lancet Gastroenterol Hepatol 2 161-176
[2]
Lazarus JV(2018)The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations Semin Liver Dis 38 181-192
[3]
Glynn SA(2005)Dynamics of viremia in early hepatitis C virus infection Transfusion 45 994-1002
[4]
Sypsa V(2005)Incidence and patterns of hepatitis C virus seroconversion in a cohort of hemodialysis patients Am J Kidney Dis 45 334-343
[5]
Miedouge M(2010)Analytical evaluation of HCV core antigen and interest for HCV screening in haemodialysis patients J Clin Virol 48 18-21
[6]
Saune K(2014)Clinical utility of hepatitis C virus core antigen quantification in patients with chronic hepatitis C J Clin Virol 61 145-148
[7]
Kamar N(2009)Viral RNA testing in hepatitis C antibody-positive veterans Am J Prev Med 36 235-238
[8]
Rieu M(2017)Hepatitis C virus core antigen: a simplified treatment monitoring tool, including for post-treatment relapse J Clin Virol 92 32-38
[9]
Rostaing L(2016)Hepatitis C core antigen testing for diagnosis of hepatitis C virus infection: a systematic review and meta-analysis Ann Intern Med 165 345-355
[10]
Izopet J(2011)Different kinetics of HBV and HCV during haemodialysis and absence of seronegative viral hepatitis in patients with end-stage renal disease Nephrol Dial Transplant 26 2648-2656